Replies to post #113388 on Avid Bioservices Inc (CDMO)

[revenue_monster]

FTM. As always thank you for your insight. The increase seems to be significant. I look forward to seeing the results later this half.

[mojojojo]

From CJ's post here #msg-64839152 another issue with the signal seeking trial is this.

"The Bavi+CP results were accomplished despite including harder-to-treat Squamous patients (8/49=16%; they yielded ORR=25%), totally excluded in the Avastin+CP trial."

The phase 2b trial doesn't have that issue.

[biopharm]

Thanks FTM.... Stated perfectly....! Eom